CSF1R and neoplasm: Unexpectedly, we were unable to detect any inhibitory effect of the anti-CD115 mAb on tumor angiogenesis, despite the fact that macrophages - required for the “angiogenic switch” and malignant transformation [17] - were clearly diminished in the tumors sampled on week 14, one week after cessation of the treatment.